Mara Marijuana

“I want to get high, but I never knew why.” David Peel 1968

Now that the overall market has performed like its starring in the film, Reefer Madness, it’s time to look at value that has the potential to grow like a weed.

A Megatrend still in infancy, medical and recreational marijuana is clearly controversial.

Added to the list of states that have legal medical and recreational pot is Vermont.

Thus far, 30 states and the District of Columbia currently have laws broadly legalizing marijuana in some form.

Eight states have adopted the most expansive laws legalizing marijuana for recreational use.

Recreational marijuana in California began on Jan. 1. Massachusetts will begin retail sales of cannabis later this year in July.

A vast majority of states allow for limited use of medical marijuana.

The majority of Americans surveyed, are in favor of legal weed.

Yet, Jeff Sessions, the Attorney General, recently annouced that he is rescinding the federal prosecutors laissez-faire attitude towards states where pot is legal.

That announcement sent marijuana stocks plummeting.

A fresh buy opportunity?

The most popular stocks that I see trading in the pot sector are GW Pharmaceuticals (GWPH) and Cara Therapeutics (CARA).

CARA, after a huge run last June, has settled into a trading range and is trying to base, provided it holds near $12.00 per share.

GWPH has done better. The all-time high made last month at $140.42 has been met with selling this month. I am watching to see if it can hold around $130.00

What interests me most, is the ETF MJX, called the Alternative Harvest ETF.

Solactive’s North American Medical Marijuana Index is made-up of a basket of 16 leading cannabis companies.

The chart shows MJX’s daily price action.

The dotted line is the 50-day moving average and the solid black line is the 200-day moving average.

The horizontal red-line is a trendline delineating the breakout from the base above $32.00. Currently, the 2 MA’s converge below at $30.20-30.95.

With the dramatic run last week up to $39.26, by week’s end, MJX dramatically fell close to support.

If there’s one thing to learn from the market since 2017, is that news matters little and price matters most.

Therefore, with the correction to support, it’s possible we will all be singing, “Give me weed instead of roses…Every puff, every shot, you looking better all the time.” Ashley Monroe

S&P 500 (SPY) The melt-up continued with QQQs, DIA and SPY making new all-time highs. Unless this gaps lower this week and gets serious follow through, not overbought so looks fine

Russell 2000 (IWM) Made new highs with 157.50 the prior high, some sellers came in and took profits, so it did not close on the intraday high. 155 now pivotal support

Dow (DIA) Gapped higher and did not fill the gap. Yes, melt-up

Nasdaq (QQQ) Not even overbought here in high territory